Concepedia
7
Publications
227
Citations
H-Index
1997
Active since
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
Tris Pharma (United States)
Les Choi is an author at Novartis (Switzerland) specializing in pharmacotherapy, nephrology, and medicine.
Top concepts
MedicineNephrologyPharmacologyPharmacotherapyPharmacokinetics
Publications per year
1997–2009
Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
Miklos Pless, Karim Belhadj, Hans D. Menssen et al. · Clinical Cancer Research · 2004 · 52 citations
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.
Lillian L. Siu, Eric K. Rowinsky, Lisa A. Hammond et al. · PubMed · 2002 · 41 citations
Influence of food intake on the bioavailability and efficacy of oral calcitonin
M.A. Karsdal, I. Byrjalsen, M. Azria et al. · British Journal of Clinical Pharmacology · 2009 · 37 citations · Full text
Pharmacokinetics of enteric‐coated mycophenolate sodium in stable pediatric renal transplant recipients
Robert B. Ettenger, Sharon Bartosh, Les Choi et al. · Pediatric Transplantation · 2005 · 28 citations
Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers
Honghui Zhou, Les Choi, Henry Lau et al. · The Journal of Clinical Pharmacology · 2000 · 27 citations
Rows per page
1–5 of 7